The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term

Matteo Stella1,2, Laura Locatelli2, Filippo Maria Sala3

  • 1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

PubMed

Insights

The Renal Risk Score (RRS) and Mayo Clinic Chronicity Score (MCCS) predict kidney outcomes in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN), unlike the Berden classification. These scores, along with hypertension and creatinine, are key for prognosis.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (ANCA-GN) is a severe kidney disease.
  • Histological scoring systems are used to predict ANCA-GN prognosis.
  • Comparing the predictive power of different scoring systems is crucial for clinical management.

Purpose of the Study:

  • To compare the histopathologic classification (Berden), Renal Risk Score (RRS), and Mayo Clinic Chronicity Score (MCCS) in predicting patient and kidney prognosis in ANCA-GN.
  • To identify which histological scoring system is most effective for assessing ANCA-GN outcomes.

Main Methods:

  • A retrospective study of 152 patients with biopsy-proven ANCA-GN and at least one year of follow-up.
  • Renal biopsies were classified using Berden, RRS, and MCCS.
  • Endpoints included end-stage kidney disease (ESKD) and ESKD or death.

Main Results:

  • Both Berden and RRS scores were associated with kidney prognosis (ESKD or death).
  • MCCS was also associated with both endpoints, particularly when comparing severity groups.
  • Multivariate analysis showed RRS and MCCS remained predictive of ESKD, while Berden classification did not.

Conclusions:

  • The Renal Risk Score (RRS) and Mayo Clinic Chronicity Score (MCCS) are independent predictors of kidney survival in ANCA-GN.
  • High serum creatinine and arterial hypertension at diagnosis also predict poor kidney outcomes.
  • The Berden classification was not found to be an independent predictor of kidney survival in this cohort.
Abstract

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...